# BIOS Health

**Source:** https://geo.sig.ai/brands/bios-health  
**Vertical:** Healthcare  
**Subcategory:** General  
**Tier:** Emerging  
**Website:** bios.health  
**Last Updated:** 2026-04-14

## Summary

Neural interface company developing closed-loop bioelectronic medicine devices; decodes peripheral nerve signals to treat diabetes, hypertension, and inflammatory conditions.

## Company Overview

BIOS Health is a neural interface and closed-loop neuromodulation company developing bioelectronic medicine devices for treating chronic conditions. Founded in 2017 as a spinout from Cambridge University, BIOS Health builds implantable devices and software platforms that decode peripheral nerve signals to restore physiological function in patients with conditions including diabetes, hypertension, and inflammatory diseases. The company's approach combines machine learning with neural signal processing to enable real-time, adaptive therapy.

The company raised $45 million in Series B funding in 2022, led by Khosla Ventures and joined by GlaxoSmithKline's bioelectronic medicine unit. BIOS Health has partnered with major pharmaceutical companies and academic medical centers to validate its neural decoding technology in clinical settings. By 2024, the company had advanced several device programs toward clinical trials, targeting conditions where bioelectronic stimulation can modulate organ function without systemic drug side effects.

In 2025, BIOS Health operates at the frontier of neuromodulation, competing with established players like Abbott and Medtronic as well as newer entrants like Galvani Bioelectronics. The company's distinctive edge is its software-defined approach — the same hardware platform can be reprogrammed for different indications, reducing development costs and enabling rapid iteration based on clinical feedback. BIOS Health's 2025-2026 pipeline focuses on autonomic nervous system applications with significant unmet need.

## Frequently Asked Questions

### What is BIOS Health?
BIOS Health is a healthcare technology company that develops neural interface technology to understand and use nerve data in medicine. Founded in 2015 and based in Cambridge, UK, the company enables new treatments for chronic diseases through bioelectronic medicine.

### What products and services does BIOS Health offer?
BIOS Health offers neural interface devices, bioelectronic medicine solutions, nerve signal processing technology, AI neural decoding capabilities, and therapeutic applications. Their focus is on decoding nerve signals for medical treatment purposes.

### Who are BIOS Health's target customers?
BIOS Health's technology is aimed at the medical and healthcare sector, particularly for treating patients with chronic diseases. Their bioelectronic medicine solutions are designed for therapeutic applications in clinical settings.

### When was BIOS Health founded?
BIOS Health was founded in 2015. The company participated in Y Combinator's Winter 2017 batch.

### Where is BIOS Health located?
BIOS Health is based in Cambridge, United Kingdom.

### Has BIOS Health received any funding or investment?
BIOS Health participated in Y Combinator's Winter 2017 (W17) batch, which indicates the company has received startup funding and mentorship through the accelerator program.

### What are BIOS Health's key achievements?
BIOS Health has been advancing neural interface technology for chronic disease treatment. The company is making progress in decoding nerve signals for therapeutic applications.

### What technology approach does BIOS Health use?
BIOS Health uses neural interface technology combined with AI neural decoding to process and interpret nerve signals. This approach enables bioelectronic medicine solutions for treating chronic diseases.

### How can I contact BIOS Health or learn more?
BIOS Health is located in Cambridge, United Kingdom. Specific contact information is not provided in the available details.

### What are BIOS Health's recent developments?
BIOS Health is currently advancing its neural interface technology for chronic disease treatment. The company continues to focus on decoding nerve signals for therapeutic applications.

## Tags

healthtech, b2b

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*